Restore Mind Medicine

G&A and Headcount Out of Line MindMed's G&A and headcount are out of line for a business of its size and need. The Board categorically rejected the notion of cost-cutting when FCM raised this with them in August 2022 and again in a recent letter to shareholders. In fact, instead of cutting expenses and reducing G&A staff: In 2022, MindMed increased G&A-related personnel by 15% In 2023, MindMed has added 13% more G&A-related personnel We believe the lack of urgency in addressing the Company's bloated cost structure will lead to further dilutive financings and are reflective of the Board and management's lack of alignment with its shareholders. Source: Company SEC Filings. 888 49

View entire presentation